MENU
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2026 All rights reserved. Tickeron Inc.
GDTC
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

CytoMed Therapeutics (GDTC) Ownership - Who owns CytoMed Therapeutics?

CytoMed Therapeutics Ltd is a pre-clinical biopharmaceutical company focused on harnessing its proprietary technologies to create novel cell-based immunotherapies for the treatment of human cancers... Show more

#MovingAverage#Momentum#MACD#Pattern#RSI#Stochastic#Aroon#Bollinger

Profile

Industry
N/A
Address
1 Commonwealth Lane
Phone
+65 62507738
Employees
42
Web
https://w2.cytomed.sg

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
12.78M
P/E Ratio
N/A
Total Cash
N/A
Projected Growth
N/A
Total Debt
N/A
Revenue
N/A
Risk (Beta)
-0.10
Dividend Yield
N/A
Total Cash/Share
N/A
Total Debt/Equity
N/A
Revenue/Share
0.02 USD as % of share price
View a ticker or compare two or three
GO
VS
Compare
VS
Compare
GDTC
Setup
Setup
Daily Signal:
Description
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
View AI-Driven Trading for GDTC
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Details
Industry
N/A
Address
1 Commonwealth Lane
Phone
+65 62507738
Employees
42
Web
https://w2.cytomed.sg